Point of Care Diagnostics Market By Product Type (Glucose Testing, HbA1c Testing, Coagulation Testing, Fertility/Pregnancy Testing, Infectious Disease Testing, Cardiac Marker Testing, Others) By Technology (Lateral Flow Assays, Molecular Diagnostics, Immunoassay Analyzers, Glucose Monitoring Systems, Rapid Tests) By Application (Blood Glucose Monitoring, Infectious Disease Testing, Cardiac Marker Testing, Cancer Marker Testing, Drug Abuse Testing) By Sample Type (Blood, Urine, Nasal Swabs, Fecal Samples) By End-User (Hospitals & Clinics, Laboratories, Home Care Settings, Physician Offices), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Point of Care Diagnostics Market Size is expected to be worth around US$ 88.3 billion by 2034 from US$ 49.8 billion in 2024, growing at a CAGR of 5.9% during the ...